Navigation Links
Children's Hospital leads projects to develop nation's first heart assist devices for young children
Date:4/3/2008

s performed more than 300 heart, heart-lung, lung and heart-liver transplants in children, including more than 200 heart transplants.

Childrens is one of the worlds most experienced centers in the use of VADs to support pediatric transplant patients awaiting donor hearts.

Until such time as a pediatric VAD is developed and approved for use, Childrens is one of several hospitals in the United States to have asked for and been granted, on a case-by-case basis, approval from the FDA to implant the Berlin Heart Excor for compassionate use. Five patients at Childrens have received Berlin Heart Excor devices and gone on to receive successful heart transplants. This VAD, developed in Germany, is an external pump that can be used in small children.

Weve been successful in using the Berlin Heart pump to keep young patients alive and healthy long enough for a donor heart to become available for transplant, and we are able to use adult pumps in our larger pediatric patients, Dr. Morell said. But getting approval to use a Berlin Heart can be a complicated process, especially when a young childs survival is dependent on it. This funding from the NIH for these projects is so crucial to our efforts to develop a pediatric VAD for use here in the United States as additional options for the hundreds of kids who suffer heart failure each year.


'/>"/>

Contact: Marc Lukasiak
marc.lukasiak@chp.edu
412-692-7919
Children's Hospital of Pittsburgh
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Clinical trial that may help patients breathe easier begins at Central DuPage Hospital
2. MRSA in hospital intensive care -- whats growing where?
3. Texas Hospital nations first to use large-scale cocoon strategy against whooping cough
4. Pennsylvania Hospital recognized for excellence in bariatric surgery
5. Childrens Hospital neurosurgeon receives grant
6. Pennsylvania Hospital surgeon receives grant to develop molecular cardiac surgery
7. Childrens Hospital studying drug with the potential to prevent/delay onset of type 1 diabetes
8. Nationwide Childrens Hospital involved in expanded access program for treatment of PKU
9. 3 out of 4 hospital patients suffer from malnutrition regardless of their pathology
10. Seattle Childrens Hospital leads $23.7 million NIH grant to study gene repair
11. Study finds environmental tests help predict hospital-acquired Legionnaires disease risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... 2014 According to a new ... (Video, RFID, Access Control, Intrusion Detection, Parking Management, Under ... Component Service Geography - Global Forecasts to 2020", published ... to be around $25 Billion in 2014 and is ... a CAGR of 8.69%. Browse 116 market ...
(Date:11/21/2014)... NEW YORK , Nov. 19, 2014  Earlier ... Board at New York College, and one of the ... for biosensor signals that are transmitted from Smartphones to ... there were Smartphones and has one of the earliest ... are discussing its usage in the military, child care, ...
(Date:11/21/2014)... MOUNTAIN VIEW, Calif. , Nov. 20, 2014 /PRNewswire/ ... for higher driver efficiency are piloting the North American ... the number of accidents growing, gesture recognition systems that ... will make a mark in the industry. ... of the Automotive Gesture Recognition Market in ...
Breaking Biology News(10 mins):Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 2Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 4
... healthy human gene to prevent blindness in mice with ... boys. , Writing in the August issue of Molecular ... they successfully used gene therapy in mice to treat ... mothers, who retain their sight, to their sons. , ...
... private practice, government and industry are coming together ... a rapidly growing area of medicine involving minimally ... first two days of the meeting focus on ... The second half of the meeting provides an ...
... their latest discovery, researchers have significantly advanced the ... constant and potentially destructive changes in gene expression. ... Nature Structural & Molecular Biology, the research is ... disease, and the ability to side-step it may ...
Cached Biology News:Gene therapy works in mice to prevent blindness that strikes boys 2Gene therapy works in mice to prevent blindness that strikes boys 3Minimally Invasive Cancer Treatments Highlighted 2Minimally Invasive Cancer Treatments Highlighted 3Study provides insight into cellular defenses against genetic mutation 2Study provides insight into cellular defenses against genetic mutation 3Study provides insight into cellular defenses against genetic mutation 4
(Date:11/26/2014)... 2014 Deep Research Report on ... in-depth research report on the Ammonium Bifluoride market, ... classification, application, and industry chain structure as well ... market analysis, including China’s domestic market as well ... China, Japan etc. regions) industry analysis covering macroeconomic ...
(Date:11/26/2014)... 2014 The Alliance for Safe ... of European physicians at the "1 ST ... Therapies" at the Spanish Ministry of Health, Social ... and the Spanish Bioindustry Association (ASEBIO), included regulators ... Spanish oncology and rheumatology societies, representatives from a ...
(Date:11/26/2014)... Charlotte, NC (PRWEB) November 25, 2014 ... High Intensity Focused Ultrasound (HIFU) devices, recently participated ... “ Small Renal Mass 360° .” Key opinion ... and therapeutic advances related to small renal masses ... learn about different ablative technologies in hands-on labs. ...
(Date:11/26/2014)... Chester, OH (PRWEB) November 25, 2014 ... Holdings, has joined the Graphel Carbon Products team as ... in sales, marketing, and customer service for the graphite ... add Miles to our team,” stated Dave Trinkley, VP ... “His wide range of experience in the graphite ...
Breaking Biology Technology:Ammonium Bifluoride Market International Analysis of Manufacturing, Technology & Trends Now at ReportsnReports.com 2Ammonium Bifluoride Market International Analysis of Manufacturing, Technology & Trends Now at ReportsnReports.com 3ASBM Presents European Physicians Survey at Spanish Ministry of Health 2SonaCare Medical Supports American Urology Association’s Small Renal Mass 360° Summit 2SonaCare Medical Supports American Urology Association’s Small Renal Mass 360° Summit 3Miles Holder Joins Graphel Corporation as Sales/Marketing Manager 2
... Inc., announced today that it has successfully completed a ... Capital on behalf of the MPM Bio IV NVS ... of a Phase 1/2 human clinical study of its ... disease undergoing surgery for arteriovenous fistula (AVF) creation. Additionally, ...
... and Helena Rojas to Director of Global Business Development Operations ... ... International Ltd., a leading provider of multilingual localization, testing and outsourced ... Arney to Vice President of Global Business Development and Helena Rojas ...
... Oncolytics Biotech Inc. (TSX:ONC, NASDAQ: ONCY ) ("Oncolytics" ... the year ended December 31, 2008. , "In 2008, ... Dr. Brad Thompson, President and CEO of Oncolytics. "The ... interim results reported in our US and UK clinical ...
Cached Biology Technology:Proteon Therapeutics Completes $38M Equity Financing; Initiates Phase 1/2 Clinical Study of PRT-201 in Hemodialysis Patients and Signs Option Agreement With Major Pharmaceutical Company 2Localization and Translation Leader CSOFT International Ltd. Recognizes Efforts of Two Key Members of its Business Development Team 2Localization and Translation Leader CSOFT International Ltd. Recognizes Efforts of Two Key Members of its Business Development Team 3Oncolytics Biotech(R) Inc. Reports Highlights and Financial Results for 2008 2Oncolytics Biotech(R) Inc. Reports Highlights and Financial Results for 2008 3Oncolytics Biotech(R) Inc. Reports Highlights and Financial Results for 2008 4Oncolytics Biotech(R) Inc. Reports Highlights and Financial Results for 2008 5Oncolytics Biotech(R) Inc. Reports Highlights and Financial Results for 2008 6Oncolytics Biotech(R) Inc. Reports Highlights and Financial Results for 2008 7Oncolytics Biotech(R) Inc. Reports Highlights and Financial Results for 2008 8Oncolytics Biotech(R) Inc. Reports Highlights and Financial Results for 2008 9
in vitro Translation, Accessory Products...
Request Info...
... Origami host strains are K-12 derivatives that ... (trxB) and glutathione reductase (gor) genes, which ... cytoplasm. Studies have shown that expression in ... in another host even though overall expression ...
Request Info...
Biology Products: